Ignacio Salamanca de la Cueva (Ignacio Salamanca)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Systematic Review

Obstructive Sleep Apnea

Top Venues

Human vaccines & immunotherapeutics

Influenza and other respiratory viruses

This page only lists publications with an associated author ORCID identifier.

Publications

Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Federico M Torres, Ignacio Salamanca de la Cueva, Michael Horn, Soeren Westerholt, Samantha Bosis, Nadia Meyer, Brigitte Cheuvart, Navpreet Virk, Rupert W Jakes, Maurine Duchenne, Peter Van den Steen
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule. Human vaccines & immunotherapeutics 20 (1) (2024)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Irati Mendia, Verónica Segura, Ángela Ruiz-Carnicer, Laura Coto, María Negrete, Joshua C D Long, Joaquin Reyes, Benito Amil, Ignacio Salamanca de la Cueva, Isabel Comino, Angel Cebolla, Carolina Sousa
Rapid Anti-tTG-IgA Screening Test for Early Diagnosis of Celiac Disease in Pediatric Populations. Nutrients 15 (23) (2023)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Gaël Dos Santos, Tamara Eckermann, Xavier Martínez-Gómez, Jose Parra, Ugo Nwoji, Ignacio Salamanca de la Cueva
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring. Influenza and other respiratory viruses 17 (3) (2023)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Markus Knuf, Marie-Laure Charkaluk, Phung Nguyen The Nguyen, Ignacio Salamanca de la Cueva, Petra Köbrunner, Lauren Mason, Maurine Duchenne, Valérie Berlaimont
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human vaccines & immunotherapeutics 19 (1) (2023)
Noelia López, Ignacio Salamanca de la Cueva, Edelmiro Vergés, Eva Suárez Vicent, Almudena Sánchez, Ana Belén López, María Belén Panizo-Santos, María Garcés-Sánchez, Abián Montesdeoca, Antonio José Rivera, Manuel Suárez Cotarelo
Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study). Human vaccines & immunotherapeutics 18 (1) (2022)
Ignacio Salamanca de la Cueva, Elisa Cinconze, Tamara Eckermann, Ugo Nwoji, Lode Godderis, Emily Lu, Xavier Martínez-Gómez, Huajun Wang, Emad Yanni
Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season. Drug safety 44 (12) (2021)
Gaël Dos Santos, Hao Wang, Pooja Jindal, Maria Rybo, Hélène Roul, Sridevi Pallem, Tamara Eckermann, Lode Godderis, Xavier Martínez-Gómez, Eric Godard, Muriel Soler, Mitra Yousefi, Ignacio Salamanca de la Cueva, Ugo Nwoji
Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season. Infectious diseases and therapy 11 (1) (2021)
Javier Diez-Domingo, Juan Carlos Tinoco, Airi Poder, Ener Cagri Dinleyici, Haylene Nell, Ignacio Salamanca de la Cueva, Tolga Ince, Edson Duarte Moreira Júnior, Khatija Ahmed, Kleber Luz, Yulia Kovshirina, Carlos Eduardo Medina Pech, Tauseefullah Akhund, Valerio Romolini, Marco Costantini, Thembile Mzolo, Barry Kunnel, Isabelle Lechevin, Marianna Aggravi, Paola Tiberi, K Narendran, Juan-Antonio Garcia-Martinez, Venere Basile, Elena Fragapane, Maria Lattanzi, Michele Pellegrini
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults. Human vaccines & immunotherapeutics (2021)